Skip to main content
David Henry III, MD, Oncology, Philadelphia, PA

DavidHoldenHenryIIIMD

Oncology Philadelphia, PA

Hematologic Oncology

Clinical Professor of Medicine, University Pennsylvania

Dr. Henry is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Henry's full profile

Already have an account?

  • Office

    230 W Washington Sq
    Philadelphia, PA 19106
    Phone+1 215-829-6088
    Fax+1 215-829-6104

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1978 - 1981
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Internal Medicine, 1975 - 1977
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 1975

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 1976 - 2024
  • FL State Medical License
    FL State Medical License 2015 - 2017
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2011-2014
  • Philadelphia Magazine Castle Connolly, 2006, 2010-2014
  • America's Top Doctors for Cancer Castle Connolly, 2010-2013

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Response-Adapted Therapy with Infusional EPOCH Chemotherapy Plus Rituximab in HIV-Associated, B-Cell Non-Hodgkin's Lymphoma
    David H. Henry, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Efficacy and Safety of Ferric Carboxymaltose Injection in Reducing Anemia in Patients Receiving Chemotherapy for Non-Myeloid Malignancies: A Phase 3, Placebo-Controlle...
    David H. Henry, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Safety and Efficacy of Brentuximab Vedotin in Combination with AVD in Stage II-IV HIV-Associated Classical Hodgkin Lymphoma: Results of the Phase 2 Study, AMC 085
    David H. Henry, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • Insights Into Anemia in Chronic Kidney Disease and Beyond: New Discoveries, Strategies, and Models of Care 
    60th American Society of Hematology Annual Meeting - 11/30/2018

Press Mentions

  • Concerns for Clinicians over 65 Grow in the Face of COVID-19
    Concerns for Clinicians over 65 Grow in the Face of COVID-19April 9th, 2020

Professional Memberships